Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis

Journal of Invasive Cardiology

Volumn 17, Issue 2, 2005, Pages 112-115

  Honda, Hidehiko ^a   Meguro, Taiichiro ^a   Takizawa, Kaname ^a   Isoyama, Shogen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS;

ADULT; ANAMNESIS; ANGINA PECTORIS; ANGIOGRAPHY; BALLOON CATHETER; BALLOON DILATATION; BIODEGRADABLE IMPLANT; CASE REPORT; CLINICAL EXAMINATION; CORONARY STENT; DRUG COATING; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; RECURRENT DISEASE; RESTENOSIS; SHORT SURVEY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMERS; REOPERATION; SIROLIMUS; STENTS;

EID: 28444441962     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-2011.
2. Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107:381-383.
3. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
4. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
5. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. J Am Coll Cardiol 2003;41:184-189.
6. Honda H, Kar S, Honda T, et al. Everolimus-eluting stents significantly inhibit neointimal hyperplasia in an experimental pig coronary model. Am J Cardiol 2002;90(Suppl 6A):72H.
7. Grube E, Gerckens U, Buellesfeld E. First human experience using a new everolimus stent coating: Early findings of the FUTURE trial. Am J Cardiol 2002;90(Suppl 6A):71H.
8. Mehran R, Dangas D, Abizaid AS, et al. Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
9. Schuler W, Sedrani R, Cottens S, et al. A new rapamycin derivative: Pharmacological properties in vitro and in vivo. Transplantation 1997;64:36-42.